Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study is designed to evaluate the safety of DTI-0009 in patients with atrial fibrillation and to find the dose of DTI-0009 that lowers heart rates in patients with atrial fibrillation with rapid ventricular response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2002
CompletedFirst Posted
Study publicly available on registry
June 20, 2002
CompletedJune 24, 2005
February 1, 2003
June 18, 2002
June 23, 2005
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Primary diagnosis of atrial fibrillation with rapid ventricular response of any duration as documented by an ECG
You may not qualify if:
- Presence of other significant cardiac disease or history of significant neurological, hepatic,cardiovascular, renal, gastrointestinal, thyroid, respiratory, rheumatologic, or hematologic disease or impairment that in the investigator's judgment is serious enough to preclude the patient from safely participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Multiple locations
Richmond, Virginia, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
June 18, 2002
First Posted
June 20, 2002
Last Updated
June 24, 2005
Record last verified: 2003-02